• CardioExcyte 96

    Combined impedance and MEA-like recordings
  • CardioExcyte 96

    For cardiac safety screening
  • CardioExcyte 96

    Next generation label-free cell analysis
  • CardioExcyte 96

    Intuitive data analysis & arrhythmia detection
  • CardioExcyte 96

    Transparent plates available for imaging

28.04.2015 | Webinar: Excited About Contraction – Combining Contractility and Excitability Measurements in Cardiotoxicity Screening

Icon CE   CardioExcyte 96

This Webinar covers the introduction of the CardioExcyte 96, a hybrid device for impedance- and MEA-type recordings from intact, beating networks of stem cell-derived cardiomyocytes.

Speakers:
"Human Cor.4U cardiomyocytes and the CardioExcyte 96: A perfect match to assess cardiotoxicity in vitro"
Dr. Ralf Kettenhofen, Axiogenesis, Cologne, Germany
"First experience with new CiPA projects on the CardioExcyte 96"
Dr. Liudmila Polounchuk, Hoffmann-La Roche, Basel, Switzerland
"New advances of the CardioExcyte 96: Pacing, Environmental Control & Cardiotoxicity Testing According to CiPA-Standards"
Dr. Sonja Stoelzle-Feix, Director Scientific Affairs, Nanion Technologies, Munich Germany

Description:
Nanion invites you to a webinar on the CardioExcyte 96 - a hybrid device for impedance- and MEA-type recordings from intact, beating networks of stem cell-derived cardiomyocytes.
Combining impedance- and MEA-recordings increases the significance of toxicity screens as both the contractility and the electrical excitability of the cellular network are taken into account.

Duration:
68 minutes


Playback

Back to Overview

Contact Us

Please type your full name.
Invalid email address.
Invalid Input
Invalid Input
Nanion Technologies GmbH

Ganghoferstr. 70A
D-80339 Munich - Germany
info@nanion.de